The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains

BACKGROUND: The Q151M multi-drug resistance (MDR) pathway in HIV-1 reverse transcriptase (RT) confers reduced susceptibility to all nucleoside reverse transcriptase inhibitors (NRTIs) excluding tenofovir (TDF). This pathway emerges after long term failure of therapy, and is increasingly observed in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mbisa, Jean L, Gupta, Ravi K, Kabamba, Desire, Mulenga, Veronica, Kalumbi, Moxmalama, Chintu, Chifumbe, Parry, Chris M, Gibb, Diana M, Walker, Sarah A, Cane, Patricia A, Pillay, Deenan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113953/
https://www.ncbi.nlm.nih.gov/pubmed/21569325
http://dx.doi.org/10.1186/1742-4690-8-31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113953/
https://www.ncbi.nlm.nih.gov/pubmed/21569325
http://dx.doi.org/10.1186/1742-4690-8-31

Ejemplares similares